Cargando…
What progress has been made in treatment of immunocompromised COVID-19 patients?
While immunocompromised patients are at very high risk of developing severe COVID 19, few of them have been enrolled in studies aimed at evaluating treatments. In the early stages of research on this disease, glucocorticoid therapy became the standard of care for patients requiring oxygen supplement...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Published by Elsevier Masson SAS.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9468055/ https://www.ncbi.nlm.nih.gov/pubmed/36108972 http://dx.doi.org/10.1016/j.idnow.2022.09.009 |